CN1031826C - 吡唑并嘧啶二膦酸酯化合物在制备治疗炎症的药物中的应用 - Google Patents

吡唑并嘧啶二膦酸酯化合物在制备治疗炎症的药物中的应用 Download PDF

Info

Publication number
CN1031826C
CN1031826C CN92105346A CN92105346A CN1031826C CN 1031826 C CN1031826 C CN 1031826C CN 92105346 A CN92105346 A CN 92105346A CN 92105346 A CN92105346 A CN 92105346A CN 1031826 C CN1031826 C CN 1031826C
Authority
CN
China
Prior art keywords
pyrimidin
phenyl
pyrazolo
methyl
propylidene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN92105346A
Other languages
English (en)
Chinese (zh)
Other versions
CN1068332A (zh
Inventor
R·A·纽金特
S·T·施拉赫特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Farmacia Earp John company
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of CN1068332A publication Critical patent/CN1068332A/zh
Application granted granted Critical
Publication of CN1031826C publication Critical patent/CN1031826C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN92105346A 1991-07-03 1992-07-03 吡唑并嘧啶二膦酸酯化合物在制备治疗炎症的药物中的应用 Expired - Fee Related CN1031826C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US72504691A 1991-07-03 1991-07-03
US72504791A 1991-07-03 1991-07-03
US725,046 1991-07-03
US725,047 1991-07-03

Publications (2)

Publication Number Publication Date
CN1068332A CN1068332A (zh) 1993-01-27
CN1031826C true CN1031826C (zh) 1996-05-22

Family

ID=27111084

Family Applications (1)

Application Number Title Priority Date Filing Date
CN92105346A Expired - Fee Related CN1031826C (zh) 1991-07-03 1992-07-03 吡唑并嘧啶二膦酸酯化合物在制备治疗炎症的药物中的应用

Country Status (19)

Country Link
US (1) US5397774A (enExample)
EP (2) EP0521622B1 (enExample)
JP (1) JPH06509100A (enExample)
CN (1) CN1031826C (enExample)
AT (1) ATE152728T1 (enExample)
AU (1) AU653428B2 (enExample)
CA (1) CA2110167A1 (enExample)
CZ (1) CZ19595A3 (enExample)
DE (1) DE69219602D1 (enExample)
FI (1) FI935944A7 (enExample)
HU (2) HUT70758A (enExample)
IE (1) IE922162A1 (enExample)
IL (1) IL102171A (enExample)
MX (1) MX9203945A (enExample)
NO (1) NO940009L (enExample)
RU (1) RU2079506C1 (enExample)
SK (1) SK277986B6 (enExample)
TW (1) TW222638B (enExample)
WO (1) WO1993001198A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07509712A (ja) * 1992-08-07 1995-10-26 ジ・アップジョン・カンパニー 抗炎症剤としてのホスホノ酢酸エステルおよびホスホノ酢酸
WO1994009017A1 (en) * 1992-10-09 1994-04-28 The Upjohn Company Pyrimidine bisphosphonate esters and (alkoxymethylphosphinyl)alkyl phosphonic acids as anti-inflammatories
WO1995011235A1 (en) * 1993-10-20 1995-04-27 The Upjohn Company Pyrimidinones as antiarthritic and anti-inflammatories
US5880111A (en) * 1995-06-07 1999-03-09 Farcasiu; Dan Therapeutic derivations of diphosphonates
US6124289A (en) * 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
US7094782B1 (en) 1996-07-24 2006-08-22 Bristol-Myers Squibb Company Azolo triazines and pyrimidines
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
IT1303672B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali nitrati di farmaci attivi nei disordini ossei
CN1217666C (zh) * 1998-12-25 2005-09-07 东丽株式会社 白介素－6产生抑制剂
WO2000059907A2 (en) 1999-04-06 2000-10-12 Du Pont Pharmaceuticals Company Pyrazolotriazines as crf antagonists
AU4203500A (en) 1999-04-06 2000-10-23 Du Pont Pharmaceuticals Company Pyrazolopyrimidines as crf antagonists
US6630476B2 (en) 2000-07-07 2003-10-07 Bristol-Myers Squibb Pharma Company Pyrrolo [3,4-d] pyrimidines as corticotropin releasing factor (CRF) antagonists
RU2183610C1 (ru) * 2000-11-15 2002-06-20 Институт молекулярной генетики РАН Высокомеченный тритием n-[3-(3-цианопиразоло[1,5-а]пиримидин-7-ил)фенил]-n-этилацетамид
AU783516B2 (en) 2001-04-30 2005-11-03 Warner-Lambert Company Methods, kits and compositions for using pyrrole derivatives
AU2006283592A1 (en) 2005-08-22 2007-03-01 Amgen Inc. Pyrazolopyridine and pyrazolopyrimidine compounds useful as kinase enzymes modulators
EP2270021A1 (en) 2009-06-18 2011-01-05 Centre National de la Recherche Scientifique Phosphonates synthons for the synthesis of phosphonates derivatives showing better bioavailability
CN104114570B (zh) * 2011-10-14 2016-08-31 齐多夫定生产和商业协会封闭式股份公司 作为人免疫缺陷病毒hiv-1产生的选择性抑制剂的氨基甲酰基膦酸酯盐
US10183949B2 (en) 2014-08-29 2019-01-22 The University Of Tokyo Pyrimidinone derivative having autotaxin-inhibitory activity
EP3187492A4 (en) * 2014-08-29 2018-05-09 The University of Tokyo Pyrimidinone derivative having autotaxin-inhibitory activity

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3683080A (en) * 1970-08-28 1972-08-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
DE2703712A1 (de) * 1977-01-29 1978-08-03 Bayer Ag Substituierte pyrimidinon eckige klammer auf (di)-thio eckige klammer zu -phosphor-(phosphon)-saeureester bzw. -esteramide, verfahren zu ihrer herstellung und ihre verwendung als insektizide, akarizide und nematizide
FR2531088B1 (fr) * 1982-07-29 1987-08-28 Sanofi Sa Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation
PH27078A (en) * 1984-12-21 1993-02-01 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonates
DE3626058A1 (de) * 1986-08-01 1988-02-11 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
IL84493A (en) * 1986-11-21 1993-01-14 Ciba Geigy Ag Aromatically substituted azacycloalkylalk - anediphosphonic acids, their preparation and pharmaceutical compositions containing them
IL84731A0 (en) * 1986-12-19 1988-05-31 Norwich Eaton Pharma Heterocycle-substituted diphosphonic acids and salts and esters and pharmaceutical compositions containing them
US5071840A (en) * 1986-12-19 1991-12-10 Norwich Eaton Pharmaceuticals, Inc. Certain heterocyclic substituted diphosphonate compounds pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism
DE3719513A1 (de) * 1987-06-11 1988-12-22 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4990503A (en) * 1988-08-12 1991-02-05 Yamanouchi Pharmaceutical Co., Ltd. Heterocyclic bisphosphonic acid derivatives
EP0650360A1 (en) * 1992-07-16 1995-05-03 The Upjohn Company Phosphono derivatives as antiinflammatory and antiarthritic agents
WO1994009017A1 (en) * 1992-10-09 1994-04-28 The Upjohn Company Pyrimidine bisphosphonate esters and (alkoxymethylphosphinyl)alkyl phosphonic acids as anti-inflammatories

Also Published As

Publication number Publication date
EP0593575A1 (en) 1994-04-27
NO940009D0 (no) 1994-01-03
NO940009L (no) 1994-01-09
EP0521622A1 (en) 1993-01-07
EP0521622B1 (en) 1997-08-13
ATE152728T1 (de) 1997-05-15
MX9203945A (es) 1993-04-01
FI935944L (fi) 1993-12-30
DE69219602D1 (de) 1997-06-12
FI935944A0 (fi) 1993-12-30
CN1068332A (zh) 1993-01-27
SK277986B6 (en) 1995-09-13
AU2240892A (en) 1993-02-11
IE922162A1 (en) 1993-01-13
HU9400003D0 (en) 1994-05-30
WO1993001198A1 (en) 1993-01-21
AU653428B2 (en) 1994-09-29
JPH06509100A (ja) 1994-10-13
IL102171A0 (en) 1993-01-14
FI935944A7 (fi) 1993-12-30
EP0593575B1 (en) 1997-05-07
CZ19595A3 (en) 1995-10-18
TW222638B (enExample) 1994-04-21
CA2110167A1 (en) 1993-01-21
HU211488A9 (en) 1995-11-28
SK150493A3 (en) 1994-11-09
HUT70758A (en) 1995-10-30
RU2079506C1 (ru) 1997-05-20
IL102171A (en) 1996-11-14
US5397774A (en) 1995-03-14

Similar Documents

Publication Publication Date Title
CN1031826C (zh) 吡唑并嘧啶二膦酸酯化合物在制备治疗炎症的药物中的应用
CN1031713C (zh) 9-嘌呤基膦酸衍生物的制备方法
CN1142933C (zh) 抑制胃酸分泌的杂环化合物、其制备方法及其药物组合物
EP1753762B1 (en) Lewis acid mediated synthesis of cyclic esters
DE69108733T2 (de) Bisphosphonsäurederivate als antiarthritische mittel.
CN1113485A (zh) 含取代的吡啶基二羟基庚烯酸或其盐的药物的制法
JP2006511563A5 (enExample)
CN1232463A (zh) 吡唑并吡啶基哒嗪酮衍生物及其制备方法
US5635495A (en) Pyrimidine bisphosphonate esters and (alkoxymethylphosphinyl)alkyl phosphonic acids as anti-inflammatories
CN1266428A (zh) 嘧啶酮化合物,包含该化合物的药物组合物以及制备该化合物的方法
Rewcastle et al. Potential antitumor agents. 63. Structure-activity relationships for side-chain analogs of the colon 38 active agent 9-oxo-9H-xanthene-4-acetic acid
EP0371921A2 (de) Phenylaliphatylaminoalkandi-phosphonsäuren
KR20170098869A (ko) 치환된 피리딜-시클로알킬-카르복실산, 그를 함유하는 조성물 및 그의 의학적 용도
JPH07309874A (ja) ハイメニアルディシン及びその誘導体並びにそれらの合成中間体の製造法並びにその合成中間体
CN1036712C (zh) 抗病毒剂[1R-(1α，2β，3α)]-2-氨基-9-[2，3-双(羟甲基)环丁基]-1，9-二氢-6H-嘌呤-6-酮的制备方法
RU2006118021A (ru) Замещенные пиридин-2-ил-тетразолы (варианты), фармацевтическая композиция, лекарственное средство, способ лечения расстройств с их использованием, способ ингибирования активации метаботропных глютаматных рецепторов -5 и способ получения пиридилпроизводных
CN1042935C (zh) 2－氰基－3－羟基丙烯酰胺类化合物及其制法、用途和药物组合物
EP0387194A1 (de) N-substituierte Aminoalkandiphosphonsäuren
JP3670309B2 (ja) 二環性複素環化合物
CN1119941A (zh) 嘧啶基二膦酸酯化合物在制备疗炎症的药物中应用
JP4058587B2 (ja) ピラゾロ〔１，５−ａ〕ピリミジン誘導体
JP2549950B2 (ja) イミダゾ［１，２−ａ］ピリジン誘導体、その製造方法及びその中間体としてのα−ハロケトン誘導体
CN88102373A (zh) 苯并咪唑衍生物及其制备方法
JPWO1999059998A1 (ja) ピラゾロ〔１，５−ａ〕ピリミジン誘導体
CN1086218A (zh) 抗炎剂膦酰基乙酸酯和酸

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C53 Correction of patent of invention or patent application
COR Change of bibliographic data

Free format text: CORRECT: PATENTEE; FROM: UPJOHN COMPANY TO: PHARMACIA UPJOHN COMPANY

CP01 Change in the name or title of a patent holder

Patentee after: Farmacia Earp John company

Patentee before: The Upjohn Co.

C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee